Cannabinoid Hyperemesis Syndrome (CHS)Symptoms, Doctors, Treatments, Advances & More
Cannabinoid Hyperemesis Syndrome (CHS) Overview
Learn About Cannabinoid Hyperemesis Syndrome (CHS)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Ohio State Outpatient Care New Albany
Thangam Venkatesan is a Gastroenterologist practicing medicine in Westerville, Ohio. Dr. Venkatesan is rated as an Elite provider by MediFind in the treatment of Cannabinoid Hyperemesis Syndrome (CHS). She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Cyclic Vomiting Syndrome, Cannabinoid Hyperemesis Syndrome (CHS), Morning Sickness, Endoscopy, and Gastrectomy.
Guillermo Putze-Burillo practices practicing medicine in Santa Cruz De Tenerife, Spain. Mr. Putze-Burillo is rated as an Elite expert by MediFind in the treatment of Cannabinoid Hyperemesis Syndrome (CHS). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Cannabinoid Hyperemesis Syndrome (CHS), Pulmonary Edema, Severe Acute Respiratory Syndrome (SARS), and COVID-19.
ETSU Physicians & Associates- Pediatric Hospitalists
Andrew Wilt is a Pediatrics provider practicing medicine in Johnson City, Tennessee. Dr. Wilt is rated as an Experienced provider by MediFind in the treatment of Cannabinoid Hyperemesis Syndrome (CHS). He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Cerebral Hypoxia, Respiratory Syncytial Virus (RSV) Infection, Asthma in Children, and Cannabinoid Hyperemesis Syndrome (CHS). Dr. Wilt is board certified in American Board Of Pediatrics.
Summary: The aim of the study is to identify which medication (haloperidol or olanzapine) is most effective in treating nausea and abdominal pain associated with cannabinoid hyperemesis using a 10-point visual analog scale with intervals of 0.5.
Summary: Cannabinoid hyperemesis syndrome (CHS) is characterized by incoercible abdominal pain and vomiting in patients with chronic cannabis use. Patients are relieved by hot showers, an easily performed diagnostic test. The prevalence of this syndrome in France is not well known. A single French study from 2021, carried out in two Marseille emergency departments, estimated a 1.6% prevalence of CHS (48 ca...